Table 1.
Summary of cannabinoids
Generic name | Trade name | Administration method | Formulation | Dosage | Pharmacokinetics |
---|---|---|---|---|---|
Dronabinol | Marinol | Oral capsule | Synthetic THC | 2.5 mg, 5 mg, 10 mg | tmax=2–4 hr. Completely absorbed (90–95%) after a single dose Alpha (plasma) half-life: 4 hr Beta (tissue) half-life: 25–36 hr* |
Nabilone | Cesamet | Oral capsule | Synthetic structural analogue of THC Methylgroup at C9 and pentyl side chain in THC substituted with a ketone group and a dimethyl heptyl side chain respectively. |
1 mg | tmax=2 hr Alpha (plasma) half-life: 2 hr Beta (tissue) half-life: 35 hr* |
Nabiximols | Sativex | Oromucosal spray | Whole plant cannabis extract | 2.7 mg THC and 2.5 mg CBD, per spray (100 μl) | tmax=98–253 min Variable plasma half-life of 85–130 min Clearance within 12–24 hr after dose* |
CBD | None | Oral capsule | Cannabis plant extract | Variable | No available information in humans4) |
THC | Namisol | Oral capsule | Cannabis plant extract | Variable | tmax=1–2 hr Half-life: 72–80 min5,6) |
THC, tetrahydrocannabinol; CBD, cannabidiol.
Marinol (Abbott Products, 2010), Cesamet (Valeant Canada, 2009), and Sativex (GW Pharmaceutical, 2010).